The Newshound

Rare cancer is deadliest in the uterus, urinary tract and trunk, Edinburgh scientists find after studying 11,700 patients

University of Edinburgh researchers studied more than 11,700 leiomyosarcoma patients, finding urinary tract tumours among those linked to the lowest survival rates.
University of Edinburgh researchers studied more than 11,700 leiomyosarcoma patients, finding urinary tract tumours among those linked to the lowest survival rates.

Leiomyosarcoma is a smooth muscle cancer that can develop in hollow organs such as the stomach, intestines, uterus and blood vessels. It ranks as the most common soft tissue sarcoma, yet treatment options remain limited. Clinicians have traditionally split cases into two categories: uterine or non-uterine disease. Scientists at the University of Edinburgh say that where a tumour originates carries meaningful prognostic weight beyond cancer stage and grade.

Patients whose tumours developed in the extremities, head and neck, or male reproductive tract had better survival outcomes.

Black, widowed and lower-income patients fared significantly worse.

Study lead Dr Robb Hollis called the findings 'critical' for designing future treatment trials.

MoreiNewsHow rare cancer behaves differently depending on locationLBCRare cancer behaves differently depending on where it is found, researchers find in breakthroughMedical XpressLocation of rare cancer impacts survival, study suggests - Medical XpressDeadline NewsScots scientists find rare cancer survival rates heavily dependent on tumour location - Deadline News
Read today's full feed at The Newshound →